The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancerYue Pan, Fang Wu, Chunhong Hu et al.|Biomarker Research|2022Cited by 57
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancerYurong Peng, Fang Wu, Zhuo Li et al.|Frontiers in Oncology|2023Cited by 15
Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune InfiltrationYucheng Fu, Weibin Zhang|Journal of Inflammation Research|2021Cited by 14